Anti-BORIS [4A7]
Invented by Prof Elena Klenova at University of Essex
Catalogue Number | 152812 |
Applications | ELISA IHC IF IP WB |
Antigen/Gene or Protein Targets | BORIS |
Synonyms | Brother of the regulator of imprinted sites, Cancer/testis antigen 27, CCCTC binding factor (zinc finger protein) like, CCCTC-binding factor, CT27, CTCF paralog, CTCF T, CTCF-like protein, Ctcfl, CTCFL_HUMAN, dJ579F20.2, HMG 1L1, HMGB1L1, MGC163358, MGC169105, MGC169106 |
Reactivity | Human |
Relevance | Reagent for research, diagnostic tool. BORIS protein has been identified as Cancer-Testis Antigen (CTA) with testis-specific paralogue of the CCCTC-binding factor. Recent studies have demonstrated that d BORIS is directly responsible for the transcriptional activation of TSP50 (testes-specific protease 50). |
Host | Mouse |
Immunogen | Synthetic peptide within the BORIS C-terminal domain (aa 614-648) (CG)GEMFPVACRETTARVKEE (NB - the first two aa do not belong to BORIS) |
Positive Control | MCF7 cell lysates |
Subclass | IgG3 kappa |
Molecular Weight (kDa) | 83 |
Recommended Growing Conditions | Vials with hybridoma cell from the liquid nitrogen storage should be rapidly thawed. After thawing, the cell suspension needs to be added slowly using a sterile pipette into 10ml of warmed HM20 medium, the suspended cells centrifuged at 1200 rpm for 10 min and the supernatant discarded. The cell pellet should be gently re-suspended in 9ml of HM20-10% HCF (Hybridoma Cloning Factor, BioVeris Corporation) and transferred into a small flask (T25). Cells should be incubated at 37°C and 10% CO2 and passaged when they were 90% confluent. Cells should be successively grown in the medium with gradually decreasing amounts of HCF from 10% to 5% to 2.5% and finally without any HCF. Depending upon the confluency of the culture, cells should be transferred from the small flask to a medium sized flask (T75) during one of these stages. |
Research Area | Cancer, Epigenetics & Nuclear Signalling |